Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.
The Latest In Technology. The Best In Care. Now is an exciting time in our profession. Over the last decade, we have seen amazing progress in the field of prosthetics and orthotics. Ever-improving materials and technology continue to focus on improving patient comfort and mobility, with greater accuracy of fit, lighter weight, and greater durability as perpetual goals. We have built our success on the foundation of skills and technical knowledge that our practitioners and technicians possess as well as the attention to detail and commitment to outstanding service that our administrative staff members practice day-after-day.Choosing a facility to provide your prosthesis, orthosis, or post-mastectomy needs is one of the most important decisions you will ever make, and I know there are many companies out there for you to consider. I encourage you to do your research, because I believe you will find that no other facility comes close to successfully providing,the latest in technology and the best in care,that we provide for those individuals who trust us with their lives.
1, 2 & 3 bedroom Apartment Homes
Closed now
